3-8745503-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033337.3(CAV3):c.115-23G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0803 in 1,594,502 control chromosomes in the GnomAD database, including 5,703 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.091 ( 750 hom., cov: 32)
Exomes 𝑓: 0.079 ( 4953 hom. )
Consequence
CAV3
NM_033337.3 intron
NM_033337.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.08
Publications
3 publications found
Genes affected
CAV3 (HGNC:1529): (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]
OXTR (HGNC:8529): (oxytocin receptor) The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-8745503-G-C is Benign according to our data. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-8745503-G-C is described in CliVar as Benign. Clinvar id is 31737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAV3 | NM_033337.3 | c.115-23G>C | intron_variant | Intron 1 of 1 | ENST00000343849.3 | NP_203123.1 | ||
CAV3 | NM_001234.5 | c.115-23G>C | intron_variant | Intron 1 of 2 | NP_001225.1 | |||
OXTR | XR_007095681.1 | n.1885-2901C>G | intron_variant | Intron 4 of 4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAV3 | ENST00000343849.3 | c.115-23G>C | intron_variant | Intron 1 of 1 | 1 | NM_033337.3 | ENSP00000341940.2 | |||
CAV3 | ENST00000397368.2 | c.115-23G>C | intron_variant | Intron 1 of 2 | 1 | ENSP00000380525.2 | ||||
CAV3 | ENST00000472766.1 | n.155+11513G>C | intron_variant | Intron 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0913 AC: 13886AN: 152018Hom.: 745 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13886
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0695 AC: 17134AN: 246556 AF XY: 0.0683 show subpopulations
GnomAD2 exomes
AF:
AC:
17134
AN:
246556
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0791 AC: 114090AN: 1442366Hom.: 4953 Cov.: 29 AF XY: 0.0775 AC XY: 55731AN XY: 718650 show subpopulations
GnomAD4 exome
AF:
AC:
114090
AN:
1442366
Hom.:
Cov.:
29
AF XY:
AC XY:
55731
AN XY:
718650
show subpopulations
African (AFR)
AF:
AC:
4001
AN:
33028
American (AMR)
AF:
AC:
1374
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
AC:
2010
AN:
26034
East Asian (EAS)
AF:
AC:
78
AN:
39630
South Asian (SAS)
AF:
AC:
3205
AN:
85726
European-Finnish (FIN)
AF:
AC:
6707
AN:
53292
Middle Eastern (MID)
AF:
AC:
159
AN:
5728
European-Non Finnish (NFE)
AF:
AC:
91835
AN:
1094424
Other (OTH)
AF:
AC:
4721
AN:
59822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
4647
9293
13940
18586
23233
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3360
6720
10080
13440
16800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0914 AC: 13910AN: 152136Hom.: 750 Cov.: 32 AF XY: 0.0920 AC XY: 6843AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
13910
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
6843
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
5240
AN:
41530
American (AMR)
AF:
AC:
807
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
257
AN:
3472
East Asian (EAS)
AF:
AC:
42
AN:
5176
South Asian (SAS)
AF:
AC:
157
AN:
4816
European-Finnish (FIN)
AF:
AC:
1322
AN:
10580
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5831
AN:
67968
Other (OTH)
AF:
AC:
133
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
627
1254
1882
2509
3136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
144
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 15, 2012
Leiden Muscular Dystrophy (CAV3)
Significance:not provided
Review Status:no classification provided
Collection Method:curation
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.